Related Experiment Video
Updated: Aug 12, 2026
09:21
Viral-mediated Labeling and Transplantation of Medial Ganglionic Eminence (MGE) Cells for In Vivo Studies
Published on: April 23, 2015
Cholinergic action on cortical glial cells in vivo
Josée Seigneur1, Daniel Kroeger, Dragos A Nita
1Laboratoire de neurophysiologie, Faculté de médecine, Université Laval, Quebec, Canada G1K 7P4.
Cerebral Cortex (New York, N.Y. : 1991)
|August 12, 2005
Summary
Glial cells in the brain primarily hyperpolarize during wakefulness transitions, influencing neuronal activity and blood flow. This in vivo study reveals key glial roles in brain state regulation.
Area of Science:
- Neuroscience
- Neurophysiology
- Glial Biology
Background:
- Understanding glial cell function in vivo is crucial for comprehending brain states.
- Previous research on glial-neuronal interactions primarily used in vitro models.
Purpose of the Study:
- To investigate in vivo glial cell interactions with neurons and blood supply during sleep-wake transitions.
- To elucidate the mechanisms underlying glial responses to cholinergic activation.
Main Methods:
- Simultaneous intracellular recordings of cortical neurons and glia in cats.
- Measurements of cerebral blood flow (CBF) and extracellular K+ concentrations.
- Cholinergic stimulation via electric stimulation and iontophoresis, with pharmacological blockade.
Main Results:
- Glial cells predominantly hyperpolarized (>80%) during cortical activation, associated with neuronal depolarization and increased CBF.
- A smaller subset of glial cells (<20%) showed depolarization, linked to decreased CBF.
- Cholinergic activation effects were modulated by glutamate and blocked by scopolamine.
Conclusions:
- Glial cell responses to cholinergic activation are complex, involving a balance of direct and indirect signaling pathways.
- In vivo glial hyperpolarization plays a significant role in regulating neuronal activity and cerebral blood flow during wakefulness.
- These findings advance our understanding of glial contributions to brain state regulation.
Related Concept Videos
01:23Cholinergic Neurons: Neurotransmission
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...